Adjuvant Therapy Following Resection of Gastroenteropancreatic Neuroendocrine Tumors Provides no Recurrence or Survival Benefit

BACKGROUND AND OBJECTIVES: Lack of high-level evidence supporting adjuvant therapy for patients with resected gastroenteropancreatic neuroendocrine tumors (GEP NETs) warrants evaluation of its non-standard of care use. METHODS: Patients with primary GEP NETs who underwent curative-intent resection a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Surg Oncol
Hauptverfasser: Barrett, James R, Rendell, Victoria, Pokrzywa, Courtney, Lopez-Aguiar, Alexandra G, Cannon, John, Poultsides, George A, Rocha, Flavio, Crown, Angelena, Beal, Eliza, Pawlik, Timothy Michael, Fields, Ryan, Panni, Roheena Z, Smith, Paula, Idrees, Kamran, Cho, Clifford, Beems, Megan, Maithel, Shishir, Weber, Sharon, Abbott, Daniel Erik
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279693/
https://ncbi.nlm.nih.gov/pubmed/32153032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.25896
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge